pd 98059 has been researched along with Cancer of Endocrine Gland in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiguchi, K | 1 |
| Yamada, M | 1 |
| Satoh, T | 1 |
| Hashimoto, K | 1 |
| Hirato, J | 1 |
| Tosaka, M | 1 |
| Yamada, S | 1 |
| Mori, M | 1 |
1 other study available for pd 98059 and Cancer of Endocrine Gland
| Article | Year |
|---|---|
Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Topics: Adult; Androstadienes; Antineoplastic Agents, Hormonal; Base Sequence; Cell Line, Tumor; Cyclin-Depe | 2009 |